UroLift works by physically holding enlarged prostate tissue out of the way so urine can flow freely. Small permanent implants pin the swollen lobes of the prostate apart, widening the urethra without cutting, heating, or removing any tissue. It’s a fundamentally mechanical fix: think of it like tiny curtain tiebacks pulling fabric to the sides of a window.
The Implant and How It’s Placed
A doctor inserts a small delivery device through the urethra (the tube you urinate through) under a camera’s guidance. The device compresses one lobe of the prostate against the outer shell of the gland, called the capsular wall. A tiny anchor is then deployed through the lobe and into that outer wall. The anchor is connected by a short length of surgical thread to a small stainless steel piece that sits on the inner surface of the urethra. As the thread stays under tension between these two points, the prostate lobe is held in a retracted position, immediately opening the channel.
Each implant has three parts: a small tab made of nitinol (a flexible metal alloy also used in stents and orthodontic wires), a stainless steel endpiece, and a monofilament polyester suture connecting them. Most patients receive between four and six implants, placed on both sides of the urethra. The whole procedure typically takes under an hour and can be done with local anesthesia, avoiding the risks that come with going under general anesthesia. Some procedures use light sedation alongside a local nerve block or anesthetic gel.
What Makes You a Candidate
UroLift is designed for men over 50 whose prostate measures between 30 and 80 cubic centimeters (roughly the size of a walnut to a small lemon). The American Urological Association recommends it as a treatment option within that volume range, provided there’s no obstructing middle lobe blocking the bladder opening. Prostates larger than 100 cc are generally considered outside the procedure’s limits.
You’ll also need a symptom score (called the IPSS) of at least 12 or 13, which corresponds to moderate or severe urinary difficulty, and a weak urine flow rate. If your symptoms are mild or your prostate falls outside the size window, other options will likely be a better fit.
Treatment for an Obstructing Middle Lobe
Earlier versions of UroLift were limited to the two side lobes of the prostate. A newer approach now addresses an obstructing middle lobe, which is a piece of prostate tissue that bulges upward into the bladder and acts like a ball valve, blocking urine from draining. In clinical trials, implants placed in the middle lobe displaced the tissue and changed the angle of obstruction at the bladder neck. Symptom improvement at three months was 170% greater than in patients who received a sham procedure, and results held steady through 12 months in both trial and real-world settings.
Middle lobe procedures did have a higher rate of needing a temporary catheter afterward, but catheter duration was short, averaging just over one day. Compared to traditional surgical removal of prostate tissue (TURP), middle lobe UroLift patients had no high-severity complications, while 14% of TURP patients in the same trial experienced serious events like blood clots, incontinence, or urethral scarring.
Recovery and What to Expect
Most men return to work within two to three days. Some temporary urinary symptoms are common in the first week or two: burning during urination, urgency, or seeing a small amount of blood. A short course of catheterization (usually about one day) is sometimes needed, though many patients go home without one. Because no tissue is cut or destroyed, healing is faster than with conventional prostate surgery, where recovery can stretch to several weeks.
How Well It Works Over Time
Five-year data from the original randomized controlled trial showed durable improvements across the board: a 36% improvement in symptom scores, a 50% improvement in quality of life, and a 44% improvement in urine flow rate. These numbers reflect averages, so individual results vary, but the trend shows that benefits hold up over years rather than fading quickly.
Retreatment rates tell a more nuanced story. At one year, about 5.9% of UroLift patients needed a second procedure, which is statistically similar to the 5.3% retreatment rate for TURP. By five years, the gap widens: 11.6% of UroLift patients required retreatment compared to 7.0% for TURP. That tradeoff is worth understanding. UroLift offers a less invasive experience and faster recovery, but a roughly 1-in-9 chance of needing additional treatment down the road.
Why Sexual Function Is Preserved
This is one of UroLift’s most significant advantages and a major reason men choose it. Conventional prostate surgeries like TURP commonly cause retrograde ejaculation, where semen travels backward into the bladder instead of exiting normally. This happens because those procedures remove or destroy tissue near the bladder neck, which controls the direction of ejaculate.
UroLift doesn’t remove or heat tissue at all. It simply repositions it. Across multiple clinical trials and real-world studies, there have been zero cases of sustained erectile dysfunction or ejaculatory dysfunction. The five-year follow-up of the original trial confirmed that both erectile and ejaculatory function remained unchanged over the entire study period. The American Urological Association specifically notes that UroLift may be offered to men who want to preserve these functions.
How It Compares to Traditional Surgery
TURP remains the gold standard for symptom relief in enlarged prostate treatment. It produces greater improvements in urine flow and symptom scores, and its retreatment rate at five years is lower. But it requires general or spinal anesthesia, a hospital stay, weeks of recovery, and carries meaningful risks of retrograde ejaculation (affecting up to 65% of patients in some studies), bleeding, and urethral scarring.
UroLift occupies a middle ground between medication and major surgery. It delivers less dramatic symptom improvement than TURP but avoids the sexual side effects, the longer recovery, and the higher complication rate. For men whose symptoms are moderate to severe but who want to avoid the tradeoffs of a more aggressive procedure, it fills a gap that didn’t exist before. The procedure is also reversible in principle: the implants can be removed, though this is rarely necessary or done in practice.